Cross Country Healthcare's (CCRN) Market Perform Rating Reiterated at Barrington Research

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report)'s stock had its "market perform" rating reissued by research analysts at Barrington Research in a note issued to investors on Tuesday,Benzinga reports. They presently have a $18.61 price target on the business services provider's stock. Barrington Research's price objective would indicate a potential upside of 32.63% from the company's previous close.

A number of other research analysts have also recently weighed in on the stock. UBS Group lowered their target price on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Wall Street Zen initiated coverage on Cross Country Healthcare in a report on Thursday, May 15th. They issued a "hold" rating on the stock. Seven equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $17.93.

Cross Country Healthcare Trading Up 1.7%

CCRN stock traded up $0.24 on Tuesday, hitting $14.03. The company had a trading volume of 87,515 shares, compared to its average volume of 575,439. Cross Country Healthcare has a 12-month low of $9.58 and a 12-month high of $18.50. The stock has a market cap of $459.98 million, a price-to-earnings ratio of -280.56, a P/E/G ratio of 3.32 and a beta of 0.37. The stock's 50-day simple moving average is $13.72 and its 200 day simple moving average is $15.91.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a positive return on equity of 5.38% and a negative net margin of 0.12%. During the same period last year, the company earned $0.19 earnings per share. The firm's quarterly revenue was down 22.6% on a year-over-year basis. Research analysts forecast that Cross Country Healthcare will post 0.53 earnings per share for the current year.

Institutional Trading of Cross Country Healthcare

Several hedge funds have recently modified their holdings of the company. Quadrant Capital Group LLC purchased a new position in shares of Cross Country Healthcare in the 4th quarter worth approximately $25,000. Plato Investment Management Ltd purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at approximately $46,000. Longfellow Investment Management Co. LLC bought a new position in Cross Country Healthcare in the first quarter worth approximately $59,000. AlphaQuest LLC grew its stake in Cross Country Healthcare by 324.6% in the first quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock worth $124,000 after purchasing an additional 6,343 shares in the last quarter. Finally, Mint Tower Capital Management B.V. purchased a new position in Cross Country Healthcare during the 4th quarter worth $182,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.